… Paris J. Baptiste, MSc, is a pharmacoepidemiology PhD student at the London School of
Hygiene and Tropical Medicine, UK. Her research uses trial replication methods in electronic …

Introduction Cardiovascular disease is a leading cause of death globally, responsible for
nearly 18 million deaths worldwide in 2017. Medications to reduce the risk of cardiovascular …

Anticoagulation therapy is recommended for patients with non-valvular atrial fibrillation (NVAF)
and an increased risk of stroke. Although apixaban showed superiority over warfarin in …

Background Cardiovascular disease (CVD) is a leading cause of death globally.
Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB), …

Objective To study the comparative effectiveness of angiotensin receptor blockers (ARB)
and angiotensin-converting enzyme inhibitors (ACEi) in ethnic minority groups in the UK. …

… We propose a new methodology for mapping the SW Paris … outcropping around the French
Paris Basin. Our methodology … of the buried substratum of the Paris Basin. The petrophysical …

Background Stroke prevention treatment guidance for patients with atrial fibrillation (AF)
uses evidence generated from randomised controlled trials (RCTs). However, applicability to …

Objective/Background: Heart Failure (HF) places substantial burden on patients, families,
communities, and care systems. Patients who suffer from HF often experience a decline in …

Aims/Objectives: To assess the feasibility of a nurse-led heart failure (HF) education program
using the Self-Care Heart Failure Index (SCHFI) instrument. Background: HF is a frequent …

Antibacterial polyolefins surfaces, combining biocidal and antiadhesive properties, were
elaborated by a covalent grafting of antimicrobial peptides (AMPs), able to kill adherent bacteria…